CX Institutional

SEC CIK: 0001737089
Latest filing: Oct 2, 2026

SEC filings (opens in a new tab)

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by CX Institutional, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overview All 13F holders of HALO Full Q3 2026 holdings

Shares (Q3 2026): 27
Value: $3.00K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2026

Holdings of HALO by CX Institutional, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2026	27	$3.00K	<0.1%	00.0%	Unchanged	Holders
Q2 2026	27	$2.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	27	$2.00K	<0.1%	+27	New	Holders